Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:2748-2750
Published online before print September 23, 2004, doi: 10.1161/01.STR.0000143325.25610.ac
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/11_suppl_1/2748    most recent
01.STR.0000143325.25610.acv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, P. H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Apoptosis
Right arrow Genetically altered mice
Right arrow Ischemic biology - basic studies

(Stroke. 2004;35:2748.)
© 2004 American Heart Association, Inc.


Articles

Future Targets and Cascades for Neuroprotective Strategies

Pak H. Chan, PhD

From the Department of Neurosurgery, Department of Neurology and Neurological Sciences, and Program in Neurosciences, Stanford University School of Medicine, Stanford, Calif.

Correspondence to Dr Pak H. Chan, Neurosurgical Laboratories, Stanford University, 1201 Welch Rd, MSLS P314, Stanford, CA 94305-5487. E-mail phchan{at}stanford.edu

Cumulative evidence suggests that apoptosis plays a pivotal role in neuronal death after cerebral ischemia in various experimental animal models. The time-dependent molecular and biochemical sequelae that lead to apoptotic cell death after the interruption of cerebral blood flow have been established. Many neuroprotective agents that target cell death pathways have been failures, and alternative strategies need to be considered. One such strategy is to target the neuronal survival signaling pathway, which involves the phosphatidylinositol 3-kinase (PI3-K)/Akt (protein kinase B) pathway. It has been demonstrated that PI3-K/Akt and downstream phosphorylated Bad and proline-rich Akt substrate survival signaling cascades are upregulated in surviving neurons in the ischemic brain that overexpresses copper-zinc superoxide dismutase activity. These studies provide an impetus for novel therapeutic targets in neuroprotective strategies in stroke.


Key Words: apoptosis • cell survival signaling • mitochondria • neuroprotection • stroke




This article has been cited by other articles:


Home page
StrokeHome page
J. A. Zivin, G. W. Albers, N. Bornstein, T. Chippendale, B. Dahlof, T. Devlin, M. Fisher, W. Hacke, W. Holt, S. Ilic, et al.
Effectiveness and Safety of Transcranial Laser Therapy for Acute Ischemic Stroke
Stroke, April 1, 2009; 40(4): 1359 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Guo, W. J. Kim, J. Lok, S.-R. Lee, E. Besancon, B.-H. Luo, M. F. Stins, X. Wang, S. Dedhar, and E. H. Lo
Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons
PNAS, May 27, 2008; 105(21): 7582 - 7587.
[Abstract] [Full Text] [PDF]